Identification | Back Directory | [Name]
4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 14-[5-(aminocarbonyl)-1H-1,2,4-triazol-1-yl]-15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)- | [CAS]
1207751-75-4 | [Synonyms]
MK-5204 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 14-[5-(aminocarbonyl)-1H-1,2,4-triazol-1-yl]-15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)- | [Molecular Formula]
C40H65N5O5 | [MOL File]
1207751-75-4.mol | [Molecular Weight]
695.97 |
Hazard Information | Back Directory | [Description]
MK-5204 is a novel orally active β-1,3-glucan synthesis inhibitor. | [Uses]
MK-5204 is an orally active β-1,3-glucan synthesis inhibitor. | [References]
[1] Apgar JM, et al. MK-5204: An orally active β-1,3-glucan synthesis inhibitor. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127357. DOI:10.1016/j.bmcl.2020.127357 |
|
|